SymBio Pharmaceuticals

SymBio Pharmaceuticals Limited focuses on developing new drugs for "unmet therapeutic areas," with an emphasis on drug research and development centered around "rare diseases such as cancer, hematological disorders, and viral infections." SymBio has established a network directly connected to global pharmaceutical companies, biotechnology firms, and university research institutions. We continuously monitor global research advancements, search for new candidate drugs, and carefully screen and introduce new candidates from vast amounts of information.